# US 2013/0158336 A1 · Use of nanoparticles in the photodynamic treatment of tumors and non-destructive testing

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0158336 A1
- Document ID: US20130158336A1
- Status: Published application
- Kind: A1
- Application number: 13/685,946
- Filed: 2012-11-27
- Published: 2013-06-20
- Earliest claimed: 2007-09-17
- Assignees: Board of Reagents, The University of Texas System; University of Houston System
- Inventors: Abdelhak Bensaoula; John Christopher Boney; A. Sam Beddar; Tina Marie Briere; Sunil Krishnan; Andrew K. Lee
- Web page: https://patentgrep.com/patent/US20130158336A1

## CPC

- A61N 5/062: {Photodynamic therapy, i.e. excitation of an agent}
- A61K 41/0071: {PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines}
- A61N 5/0601: {Apparatus for use inside the body}
- A61N 5/10: X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy (A61N5/01 takes precedence)
- B82Y 5/00: Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
- A61N 2005/065: {Light sources therefor}
- A61N 2005/1098: {Enhancing the effect of the particle by an injected agent or implanted device}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES

## Abstract

A method for generating light intensity inside a tumor to aid in the treatment of diseases such as cancer is disclosed. The light is generated inside the body to perform a modified photodynamic therapy treatment (PDT) that allows treatment of body regions that are inaccessible by normal PDT procedures. In addition, the use of two spatially and temporally coincident treatment modalities, i.e. radiation and PDT, have the potential for significant biological synergy in the tumor.

## Claims

### Claim 1

A method for treating tumors in animals including humans by photo-dynamic therapy comprising the step of:
administering an effective amount of nano-particles to a target site an animal including a cancerous growth and/or tumor,
administering an photo effective amount of a photosensitizer molecules to the target site,
applying a first radiation type to the target site, and
applying a second radiation type to the target site,
where the two administering steps can be performed collectively or separately, where the nano-particles are independent of the photosensizer, where the radiation generates energetic electrons, the nano-particles are capable of absorbing a portion of the electrons, where the nano-particles have a bandgap of a value sufficient to convert a portion of the absorbed electrons into photons having a frequency range corresponding to an absorption frequency range of the photosensitizer molecules, and where the photosensitizer molecules absorb a portion of the photons activating oxygen to form oxygen radicals capable of producing a localized photodynamic therapeutic affect reducing a number of cancer cells or reducing a size of the tumor.

### Claim 2 (depends on 1)

The method of claim 1, wherein the animal is an human and the cancer or tumor is selected from the group consisting of carcinomas, melanomas, lymphomas, plasmocytoma, sarcoma, glioma, thymoma, brain tumor, myeloma, leukemia, or a tumor of pharynx, bones, joints, soft tissue, skin, breast, eye, orbit, the nervous system, endocrine system, urinary system, genital system, respiratory system, digestive system, oral cavity and/or combinations thereof.

### Claim 3 (depends on 1)

The method of claim 1, wherein the nano-particles comprise semiconductor nano-particles.

### Claim 4 (depends on 3)

The method of claim 3, wherein the semiconductor nano-particles comprise binary compounds from Groups II-VI or Groups III-V, ternary compounds from Groups II-VI or Groups III-V, quaternary compounds from Groups II-VI or Groups III-V, or mixtures or combinations thereof.

### Claim 5 (depends on 4)

The method of claim 4, wherein the nano-particles are doped with transition metals selected from the group consisting of Groups IB, IIB, IIIB, IVB, VB, VIB, VIIB, VIII transition metals and mixtures thereof.

### Claim 6 (depends on 4)

The method of claim 4, wherein the semiconductor nanoparticles comprise a single core compound, a single (core) compound and a different second outer (shell) compound or mixtures or combinations thereof.

### Claim 7 (depends on 6)

The method of claim 6, wherein the semiconductor nanoparticles further comprise a non-semiconductor surface layer material, where the surface layer material comprises silicon dioxide, or a molecule comprising a sulfur, phosphorous, or amine group, or a molecule selected from the group consisting of a synthetic polymer, a peptide or polypeptide, an antibody or a fragment thereof, a nucleic acid, a carbohydrate molecule, a lipid molecule, a drug, or synthetic molecule or mixtures or combinations thereof.

### Claim 8 (depends on 1)

The method of claim 1, wherein the semiconductor nanoparticles further include a targeting molecule, wherein the targeting molecule binds specifically to molecules localized within the tumor, where the targeting molecule is a peptide or an antibody or the targeting molecule binds specifically to angiogenic molecules in the endothelium of the tumor.

### Claim 9 (depends on 1)

The method of claim 1, wherein the administering step is by implanting a device containing the semiconductor nanoparticles, injecting the nano-particles directly into the target site, injecting the nano-particles into a body cavity, injecting the nano-particles intravenously, injecting the nano-particles intra-arterially, or a combination of these administering steps.

### Claim 10 (depends on 1)

The method of claim 1, wherein the radiation is in a form selected from x-rays having a frequency range between about 1 keV to 50,000 keV, microbeam arrays of x-rays, radioisotopes, electrons, protons, ion beams, or neutrons.

### Claim 11 (depends on 1)

The method of claim 1, wherein the two administering steps are performed separately, in either order.

### Claim 12

A method comprising the steps of:
providing a structure including a substructure including nano-particles, where the nano-particles are capable of absorbing a portion of the electrons generated when the structure containing the nano-particles is irradiated by ionizing radiation and where nano-particles having a bandgap of a value sufficient to convert a portion of the absorbed electrons into photons having a desired frequency range,
irradiating the structure with ionizing radiation, and
using the photons generated by the nano-particles to perform a useful task.

### Claim 13 (depends on 12)

The method of claim 12, wherein the substructure includes a photo powered device capable of using the photons to perform the useful task.

### Claim 14 (depends on 13)

The method of claim 13, wherein the photo powered device is a communication device, a data collection and communication device, or a structure characterization device.

### Claim 15 (depends on 12)

The method of claim 12, wherein the nano-particles comprise semiconductor nano-particles.

### Claim 16 (depends on 15)

The method of claim 15, wherein the semiconductor nano-particles comprise binary compounds from Groups II-VI or Groups III-V, ternary compounds from Groups II-VI or Groups III-V, quaternary compounds from Groups II-VI or Groups III-V, or mixtures or combinations thereof.

### Claim 17 (depends on 15)

The method of claim 15, wherein the nano-particles are doped with transition metals selected from the group consisting of Groups IB, IIB, IIIB, IVB, VB, VIB, VIIB, VIII transition metals and mixtures thereof.

### Claim 18 (depends on 15)

The method of claim 15, wherein the semiconductor nanoparticles comprise a single core compound, a single (core) compound and a different second outer (shell) compound or mixtures or combinations thereof.

### Claim 19 (depends on 18)

The method of claim 18, wherein the semiconductor nanoparticles further comprise a non-semiconductor surface layer material, where the surface layer material comprises silicon dioxide, or a molecule comprising a sulfur, phosphorous, or amine group, or a molecule selected from the group consisting of a synthetic polymer, a peptide or polypeptide, an antibody or a fragment thereof, a nucleic acid, a carbohydrate molecule, a lipid molecule, a drug, or synthetic molecule or mixtures or combinations thereof.

### Claim 20 (depends on 11)

The method of claim 11, wherein the ionizing radiation is in a form selected from x-rays having a frequency range between about 1 keV to 50,000 keV, microbeam arrays of x-rays, radioisotopes, electrons, protons, ion beams, or neutrons.
